## Mechanism: 
- human IgG1/κ monoclonal antibody against IL-1β ➔ preventing IL-1β binding to IL-1 receptors
## Indications: 
- active SJIA in children 2 years or older, CAPS (familial cold autoinflammatory syndrome and Muckle-Wells syndrome subtypes), gout